Cargando…
The Vasoactive Mas Receptor in Essential Hypertension
The renin–angiotensin–aldosterone system (RAAS) has been studied extensively, and with the inclusion of novel components, it has become evident that the system is much more complex than originally anticipated. According to current knowledge, there are two main axes of the RAAS, which counteract each...
Autores principales: | Povlsen, Amalie L., Grimm, Daniela, Wehland, Markus, Infanger, Manfred, Krüger, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019597/ https://www.ncbi.nlm.nih.gov/pubmed/31963731 http://dx.doi.org/10.3390/jcm9010267 |
Ejemplares similares
-
SARS‐CoV‐2 and hypertension
por: Ravichandran, Briyanth, et al.
Publicado: (2021) -
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
por: Enevoldsen, Frederik C., et al.
Publicado: (2020) -
Kinase-Inhibitors in Iodine-Refractory Differentiated Thyroid Cancer—Focus on Occurrence, Mechanisms, and Management of Treatment-Related Hypertension
por: Kaae, Anne Christine, et al.
Publicado: (2021) -
Potential Beneficial Effects of Vitamin D in Coronary Artery Disease
por: Legarth, Christian, et al.
Publicado: (2019) -
The Impact of Vitamin D in the Treatment of Essential Hypertension
por: Legarth, Christian, et al.
Publicado: (2018)